|
Market Closed -
Nasdaq Copenhagen
20:20:00 17/11/2026 +04
|
5-day change | 1st Jan Change | ||
| 3,502.00 DKK | -0.77% |
|
-2.21% | +72.77% |
| 11-16 | Ninety One Takes a Hit, Exosens Activates Night Vision | |
| 11-16 | UBS raises price target for Genmab to DKK 4,900 (3,100), reiterates buy | FW |
| Market Cap | 223B 32.91B 29.87B 27.6B 24.9B 47B 3,075B 48.8B 333B 132B 1,659B 123B 121B 5,242B | P/E 2026 * |
41.9x | P/E 2027 * | 32.7x |
|---|---|---|---|---|---|
| Enterprise Value | 242B 35.7B 32.41B 29.94B 27.01B 50.98B 3,335B 52.94B 361B 143B 1,800B 134B 131B 5,686B | EV / Sales 2026 * |
8.08x | EV / Sales 2027 * | 6.47x |
| Free-Float |
94.31% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| GMAB | Delayed | |
| GMABc | Real-time | ||
| GNMSF | Delayed | ||
| GMAB N | End-of-day quote | ||
| GE9 | End-of-day quote | ||
| 0MGB | Real-time | ||
| GE9 | Real-time | ||
| GE9 | Delayed | ||
| GE9 | Real-time | ||
| 0MGB | Delayed | ||
| GMAB | End-of-day quote | ||
| GE9 | Delayed | ||
| GE9 | Delayed |
Last Transcript: Genmab A/S
| 1 day | -0.77% | ||
| 1 week | -2.21% | ||
| Current month | -10.48% | ||
| 1 month | +37.77% | ||
| 3 months | +66.44% | ||
| 6 months | +107.16% | ||
| Current year | +72.77% |
| 1 week | 3,423 | 3,625 | |
| 1 month | 2,473 | 3,947 | |
| Current year | 1,512 | 3,947 | |
| 1 year | 1,512 | 3,947 | |
| 3 years | 1,157 | 3,947 | |
| 5 years | 1,157 | 3,947 | |
| 10 years | 786.2 | 3,947 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/06/2010 | |
Anthony Pagano
DFI | Director of Finance/CFO | 48 | 01/03/2020 |
Rayne Waller
CTO | Chief Tech/Sci/R&D Officer | - | 16/08/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | 01/11/2003 | |
| Director/Board Member | 58 | 01/01/2015 | |
| Director/Board Member | 75 | 01/01/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/12/25 | Exercice | Director | 189 | 0.0003% | ||
| 01/12/25 | Exercice | Director | 189 | 0.0003% | ||
| 01/12/25 | Exercice | Director | 283 | 0.0004% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.77% | -2.21% | +77.27% | +57.96% | 32.9B | ||
| +1.15% | -2.81% | +53.73% | +71.00% | 65.56B | ||
| -2.64% | -1.13% | +7.82% | +88.90% | 60.41B | ||
| -1.07% | +0.30% | +22.91% | +86.76% | 55.76B | ||
| -0.32% | -3.21% | +8.97% | +119.61% | 46.98B | ||
| -1.91% | -5.40% | +20.44% | +27.11% | 43.63B | ||
| -0.70% | +1.43% | +14.05% | +45.20% | 36.7B | ||
| -1.83% | -14.97% | +137.42% | +669.60% | 36.09B | ||
| -1.05% | +2.31% | -38.07% | +392.55% | 26.96B | ||
| -0.94% | -5.36% | +38.96% | -3.04% | 24.45B | ||
| Average | -1.00% | -1.98% | +34.35% | +155.57% | 43B | |
| Weighted average by Cap. | -0.94% | -1.65% | +33.83% | +139.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 29.99B 4.42B 4.01B 3.7B 3.34B 6.31B 413B 6.55B 44.64B 17.66B 223B 16.57B 16.23B 704B | 36.34B 5.35B 4.86B 4.49B 4.05B 7.65B 500B 7.94B 54.1B 21.4B 270B 20.09B 19.66B 853B |
| Net income | 5.33B 785M 713M 659M 594M 1.12B 73.37B 1.16B 7.94B 3.14B 39.59B 2.95B 2.88B 125B | 7.05B 1.04B 942M 871M 785M 1.48B 96.99B 1.54B 10.49B 4.15B 52.34B 3.89B 3.81B 165B |
| Net Debt | 18.93B 2.79B 2.53B 2.34B 2.11B 3.98B 261B 4.14B 28.19B 11.15B 141B 10.47B 10.24B 444B | 11.78B 1.74B 1.58B 1.46B 1.31B 2.48B 162B 2.57B 17.54B 6.94B 87.53B 6.51B 6.38B 277B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/11/26 | DKK 3,502.00 | -0.77% | 152,354 |
| 16/11/26 | DKK 3,529.00 | +2.35% | 152,134 |
| 13/11/26 | DKK 3,448.00 | -2.32% | 130,080 |
| 12/11/26 | DKK 3,530.00 | -0.87% | 276,750 |
| 11/11/26 | DKK 3,561.00 | -0.56% | 201,425 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- GMAB Stock
Select your edition
All financial news and data tailored to specific country editions




















